Dupont DM - Search Results

1

Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.

Dupont DM, Madsen JB, Hartmann RK, Tavitian B, Ducongé F, Kjems J, Andreasen PA. Dupont DM, et al. RNA. 2010 Dec;16(12):2360-9. doi: 10.1261/rna.2338210. Epub 2010 Oct 20. RNA. 2010. PMID: 20962041 Free PMC article.

2

Mutational analysis of plasminogen activator inhibitor-1.

Wind T, Jensen JK, Dupont DM, Kulig P, Andreasen PA. Wind T, et al. Among authors: dupont dm. Eur J Biochem. 2003 Apr;270(8):1680-8. doi: 10.1046/j.1432-1033.2003.03524.x. Eur J Biochem. 2003. PMID: 12694181 Free article.

3

Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal.

Jensen JK, Durand MK, Skeldal S, Dupont DM, Bødker JS, Wind T, Andreasen PA. Jensen JK, et al. Among authors: dupont dm. FEBS Lett. 2004 Jan 2;556(1-3):175-9. doi: 10.1016/s0014-5793(03)01405-4. FEBS Lett. 2004. PMID: 14706846 Free article.

4

Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis.

Durand MK, Bødker JS, Christensen A, Dupont DM, Hansen M, Jensen JK, Kjelgaard S, Mathiasen L, Pedersen KE, Skeldal S, Wind T, Andreasen PA. Durand MK, et al. Among authors: dupont dm. Thromb Haemost. 2004 Mar;91(3):438-49. doi: 10.1160/TH03-12-0784. Thromb Haemost. 2004. PMID: 14983218 Review.

5

Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached beta-strand 1C.

Dupont DM, Blouse GE, Hansen M, Mathiasen L, Kjelgaard S, Jensen JK, Christensen A, Gils A, Declerck PJ, Andreasen PA, Wind T. Dupont DM, et al. J Biol Chem. 2006 Nov 24;281(47):36071-81. doi: 10.1074/jbc.M606851200. Epub 2006 Oct 3. J Biol Chem. 2006. PMID: 17018527 Free article.

6

A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state.

Mathiasen L, Dupont DM, Christensen A, Blouse GE, Jensen JK, Gils A, Declerck PJ, Wind T, Andreasen PA. Mathiasen L, et al. Among authors: dupont dm. Mol Pharmacol. 2008 Sep;74(3):641-53. doi: 10.1124/mol.108.046417. Epub 2008 Jun 17. Mol Pharmacol. 2008. PMID: 18559377

7

Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements.

Blouse GE, Dupont DM, Schar CR, Jensen JK, Minor KH, Anagli JY, Gårdsvoll H, Ploug M, Peterson CB, Andreasen PA. Blouse GE, et al. Among authors: dupont dm. Biochemistry. 2009 Mar 3;48(8):1723-35. doi: 10.1021/bi8017015. Biochemistry. 2009. PMID: 19193026

8

Biochemical properties of plasminogen activator inhibitor-1.

Dupont DM, Madsen JB, Kristensen T, Bodker JS, Blouse GE, Wind T, Andreasen PA. Dupont DM, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(4):1337-61. doi: 10.2741/3312. Front Biosci (Landmark Ed). 2009. PMID: 19273134 Free article. Review.

9

RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.

Madsen JB, Dupont DM, Andersen TB, Nielsen AF, Sang L, Brix DM, Jensen JK, Broos T, Hendrickx ML, Christensen A, Kjems J, Andreasen PA. Madsen JB, et al. Among authors: dupont dm. Biochemistry. 2010 May 18;49(19):4103-15. doi: 10.1021/bi100066j. Biochemistry. 2010. PMID: 20387790

10

In vivo validation of free-space fluorescence tomography using nuclear imaging.

Garofalakis A, Dubois A, Kuhnast B, Dupont DM, Janssens I, Mackiewicz N, Dollé F, Tavitian B, Ducongé F. Garofalakis A, et al. Among authors: dupont dm. Opt Lett. 2010 Sep 15;35(18):3024-6. doi: 10.1364/OL.35.003024. Opt Lett. 2010. PMID: 20847766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters